Literature DB >> 9986857

Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer.

M Poljak1, A Brencic, K Seme, A Vince, I J Marin.   

Abstract

In the present study we comparatively evaluated the first- and second-generation Digene Hybrid Capture assays for detection of human papillomaviruses (HPV) associated with high or intermediate risk for cervical cancer in cervical specimens. Concordant results were obtained with 468 of 483 (96.8%) specimens. All 15 specimens which gave repeatedly discordant results were positive by the second-generation test only, and 14 of them tested PCR positive. The enhanced sensitivity of the second-generation assay is mainly a result of the reformulation of hybridization reagents and, to a lesser extent, a result of the addition of new HPV probes.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9986857      PMCID： PMC84559     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Rapid detection and typing of human papillomaviruses by consensus polymerase chain reaction and enzyme-linked immunosorbent assay.

Authors:  M Poljak; K Seme
Journal:  J Virol Methods       Date:  1996-02       Impact factor: 2.014

2.  Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA.

Authors:  S Cavuslu; C Mant; W G Starkey; J M Bible; C Biswas; B Kell; P Rice; J M Best; J Cason
Journal:  J Med Virol       Date:  1996-08       Impact factor: 2.327

Review 3.  Human papillomavirus tests.

Authors:  R Reid; A T Lorincz
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1995-03

4.  Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms.

Authors:  H U Bernard; S Y Chan; M M Manos; C K Ong; L L Villa; H Delius; C L Peyton; H M Bauer; C M Wheeler
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

5.  Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.

Authors:  M H Schiffman; N B Kiviat; R D Burk; K V Shah; R W Daniel; R Lewis; J Kuypers; M M Manos; D R Scott; M E Sherman
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

6.  Human papillomavirus detection by hybrid capture and its possible clinical use.

Authors:  A Farthing; P Masterson; W P Mason; K H Vousden
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

7.  Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens.

Authors:  D R Brown; K Rawlings; V Handy; K H Fife; J T Bryan; H Cramer; M Graham
Journal:  J Med Virol       Date:  1996-02       Impact factor: 2.327

8.  Intermethod variation in detection of human papillomavirus DNA in cervical smears.

Authors:  H L Smits; L J Bollen; S P Tjong-A-Hung; J Vonk; J Van Der Velden; F J Ten Kate; J A Kaan; B W Mol; J Ter Schegget
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

9.  Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test.

Authors:  X W Sun; A Ferenczy; D Johnson; J P Koulos; O Lungu; R M Richart; T C Wright
Journal:  Am J Obstet Gynecol       Date:  1995-11       Impact factor: 8.661

10.  Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and Southern blot techniques.

Authors:  D R Brown; J T Bryan; H Cramer; K H Fife
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948
View more
  15 in total

1.  Quantitative screening of single copies of human papilloma viral DNA without amplification.

Authors:  Jiangwei Li; Ji-Young Lee; Edward S Yeung
Journal:  Anal Chem       Date:  2006-09-15       Impact factor: 6.986

2.  Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.

Authors:  C E Depuydt; I H Benoy; J F A Beert; A M Criel; J J Bogers; M Arbyn
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

3.  Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening.

Authors:  Joël Coste; Béatrix Cochand-Priollet; Patricia de Cremoux; Catherine Le Galès; Isabelle Cartier; Vincent Molinié; Sylvain Labbé; Marie-Cécile Vacher-Lavenu; Philippe Vielh
Journal:  BMJ       Date:  2003-04-05

4.  Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.

Authors:  Anna Söderlund-Strand; Per Rymark; Pia Andersson; Joakim Dillner; Lena Dillner
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test.

Authors:  Hannah P Yang; David K Walmer; Delson Merisier; Julia C Gage; Laura Bell; Sameera Rangwala; Niwashin Shrestha; Lori Kobayashi; Paul S Eder; Philip E Castle
Journal:  J Virol Methods       Date:  2011-05-27       Impact factor: 2.014

6.  Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests.

Authors:  Matthew P Stevens; Elice Rudland; Suzanne M Garland; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

7.  Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.

Authors:  Yongjung Park; Eunhee Lee; Jonghyeon Choi; Seri Jeong; Hyon-Suk Kim
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

8.  Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.

Authors:  Manola Comar; Michelle R Iannacone; Giorgia Casalicchio; Sandrine McKay-Chopin; Massimo Tommasino; Tarik Gheit
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.

Authors:  Mario Poljak; Bostjan J Kocjan; Anja Kovanda; Maja M Lunar; Snjezana Zidovec Lepej; Ana Planinic; Katja Seme; Adriana Vince
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

10.  Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

Authors:  Matthew P Stevens; Suzanne M Garland; Elice Rudland; Jeffrey Tan; Michael A Quinn; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.